4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001104659-23-009975
Chief Scientific Officer gave up 2,183 shares (to pay taxes)
- Chief Scientific Officer acquired 1,436 shares (grant or award)
- Chief Scientific Officer acquired 6,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roberts M Scot Chief Scientific Officer | 2023-01-31 | Grant or award | +1,436 | $10.21 | $14,659 | 10,473 | D: show line 1 in the form |
| Roberts M Scot Chief Scientific Officer | 2023-02-01 | Option exercise | +6,166 | 16,639 | D: show line 2 in the form | ||
| Roberts M Scot Chief Scientific Officer | 2023-02-01 | Shares withheld for taxes | −2,183 | $13.78 | $30,082 | 14,456 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roberts M Scot Chief Scientific Officer | 2023-02-01 | Option exercise · Restricted Stock Units | −6,166 | 12,332 | D: show line 4 in the form |
Loading xslF345X03/tm235311-4_4seq1.xml…